The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

AirFluSal® Forspiro® 50 microgram/500 microgram/dose, inhalation powder, predispensed

Rowex LtdPA0711/237/002

Main Information

Trade NameAirFluSal® Forspiro® 50 microgram/500 microgram/dose, inhalation powder, predispensed
Active SubstancesSalmeterol
Fluticasone propionate
Dosage FormInhalation powder, pre-dispensed
Licence HolderRowex Ltd
Licence NumberPA0711/237/002

Group Information

ATC CodeR03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
R03AK06 salmeterol and fluticasone


License statusAuthorised
Licence Issued14/11/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back